Novici is a biotech company providing novel technologies for accelerating research in Directed Evolution and Synthetic Biology.

We began operations in July 2007 to commercialize our GRAMMR gene shuffling technology. Since then, our scientists have developed additional molecular and bioinformatics tools for commercial application to improving products through directed evolution. Click here for more on these technologies.
 
 
We assist our clients in improving their products by creating superior molecular evolution workflows with our unique combination of molecular tools and laboratory capabilities.
Novici’s modern research facility is fully outfitted to accommodate multiple high throughput directed evolution workflows. Overall, the flexibility of our unique set of directed evolution technologies enable us to create seamless workflows customized in scope and scale to the particular needs of the client. These services are applicable in a number of product categories including biopharmaceutical applications, biocatalysis, and agricultural biotechnology.
Novici’s scientists are innovative, solution oriented, and committed to producing high quality results for our clients. Our diverse skills allow us to take a lead role in the entire directed evolution process from library construction, expression, and protein purification, to identification of assay hits and further refinement of their activities.